Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
'Heated Rivalry's Ilya Rozanov is now a queer icon in Russia - 2Kids may be more likely to get the new ‘Cicada’ variant of Covid-19, scientists say. Here’s what to know about BA.3.2
- 3Figure out How to Acquire Rewarding Open Record Rewards
- 4Gulf countries continue to face Iran attacks as criticial energy infrastructure at risk
- 5The 10 Most Noteworthy Games in History
- Brazil expands pesticide packaging reverse logistics
- Jersey's wellbeing score is below UK and France
- Want to make America healthy again? Stop fueling climate change
- NI economy losing momentum due to Iran crisis
- My daughter is in the #1 movie in the country. She still has to finish her math homework.
- ‘Harry Potter and the Philosopher’s Stone’ trailer is raising eyebrows among Potterheads: ‘Where’s the whimsical color?’
- Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
- I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works.
- Germany's Lufthansa enters race for stake in Portuguese airline TAP
